dr. julie r. gralow on her2-positive early breast cancer
Published 3 years ago • 32 plays • Length 10:05Download video MP4
Download video MP3
Similar videos
-
38:02
dr. julie gralow on breast cancer
-
7:13
asco 2023 exclusive: julie gralow, cmo of asco
-
0:32
julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
-
1:27
dr. julie gralow on the importance of genetic testing for breast cancer
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
5:22
2024 top doctor spotlight: dr. larry norton
-
29:59
breast cancer awareness: dr. potdevin, dr. george and aimee roehler
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
13:08
her2 positive breast cancer: everything you must know
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
1:08
mednews week conference promo (2/2) - dr. julie r. gralow (asco & university of washington)
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
1:30
mednews week conference promo (1/2) - dr. julie r. gralow (asco & university of washington)
-
1:12
julie lang, md | cleveland clinic breast cancer program
-
42:02
asco breast cancer update | jane meisel, md | 2022 review and renew sedona
-
1:29
the genetics of breast cancer complete response
-
2:17
her2: a driver of breast cancer
-
2:31
what is her2 low in breast cancer?
-
4:26
altto trials findings for treating her2 breast cancer - mayo clinic